Pages

Monday, 11 March 2019

Here's Why Arrowhead Pharmaceuticals Gained 38.2% in February


Here's Why Arrowhead Pharmaceuticals Gained 38.2% in February



Investors cheered the news in a fiscal first-quarter 2019 earnings report.

No comments:

Post a Comment